精雅印刷集团(08391.HK):预计买方尽调及双方协议讨论将于9月至10月期间完成
格隆汇9月2日丨精雅印刷集团(08391.HK)公布,就潜在卖方冠双拟向潜在买方Global Fortune出售其所持3.3亿股公司股份(占公司现有已发行股本的75%),于2019年9月2日,潜在买方正对公司进行尽职审查。潜在买方及潜在卖方正就有关可能转让的正式协议的条款进行讨论。预期尽职审查及讨论将于2019年9月至10月期间完成。
据悉,冠双由由彩贝拥有90%及由湛冠拥有10%,而彩贝乃由公司主席、行政总裁兼执行董事苏永强全资拥有,湛冠由公司执行董事梁树坚全资拥有。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.